Charles P. Xavier

495 citations
12 papers · 396 indexed · h-index 8
Topics
Prostate Cancer Treatment and Research (7 papers)Fibroblast Growth Factor Research (2 papers)Ubiquitin and proteasome pathways (2 papers)
Partner nations
United States

In The Last Decade

Charles P. Xavier

12 papers receiving 394 citations

Peers

Charles P. Xavier
Comparison fields: 5 of 55
  • Molecular Biology 292
  • Cell Biology 72
  • Oncology 71
  • Pulmonary and Respiratory Medicine 69
  • Immunology 59
Replace Buyou Chen with:
Buyou Chen China
Zongling Ji United Kingdom
Keika Zen Japan
C Schimanski Germany
Christine Gauglhofer Austria
Francesca Siepi Italy
Luai Zarour United States
Juanzhi Chen China
Candice Alexandra Grzelak United States
Florence Defresne Belgium
Charles P. Xavier relative to Buyou Chen China Buyou Chen's profile →
Citations per field
00.5×1.5×1.8×
Buyou Chen · 1×
Citations per year

Countries citing papers authored by Charles P. Xavier

Since Specialization
Citations

This map shows the geographic impact of Charles P. Xavier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles P. Xavier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles P. Xavier more than expected).

Fields of papers citing papers by Charles P. Xavier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles P. Xavier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles P. Xavier. The network helps show where Charles P. Xavier may publish in the future.

Co-authorship network of co-authors of Charles P. Xavier

This figure shows the co-authorship network connecting the top 25 collaborators of Charles P. Xavier. A scholar is included among the top collaborators of Charles P. Xavier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles P. Xavier. Charles P. Xavier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
#WorkIndexed citations
1 9
2 1
3 44
4 1
5 33
6 1
7 18
8 36
9 138
10 82
11 32
12 1

About Charles P. Xavier

Charles P. Xavier is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Clinical Biochemistry, having authored 12 papers that have together received 396 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (7 papers), Fibroblast Growth Factor Research (2 papers) and Ubiquitin and proteasome pathways (2 papers). The work is most often cited by research in Cell Biology (72 citations), Hepatology (35 citations) and Molecular Biology (292 citations). Charles P. Xavier has collaborated with scholars based in United States. Frequent co-authors include Jeffrey S. Rubin, Mitchell Ho, Wei Gao, Yen Phung, Heungnam Kim, Mingqian Feng, Yoshiro Chuman, Bolormaa Baljinnyam, Aykut Üren and Shiv Srivastava. Their work appears in journals such as Hepatology, Cancer Research and Molecular Biology of the Cell.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026